Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide for cerebral blood flow in acute ischemic stroke
2016-001219-18Phase 2Terminated
- Sponsor
- Herlev & Gentofte Hospital
- Start
- Mar 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of exenatide in ischemic stroke, sponsored by Herlev & Gentofte Hospital. Primary endpoints: Change in mean blood flow velocity in the middle cerebral artery and Change in cortical oxygenation. Started Mar 2016; status: terminated.
02
Drugs
exenatide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2016-001219-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001219-18.